(Q80174480)
Statements
Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial (English)
Martin Borggrefe
Witold Ruzyllo
Berndt Lüderitz
A-COMET-II Investigators